搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
avir
/
财务摘要
Atea Pharmaceuticals Inc
AVIR
添加自选
5.310
USD
+0.130
+2.51%
收盘 09-11 16:00(美东)
426.69M
总市值
亏损
市盈率 TTM
Atea Pharmaceuticals Inc
5.310
+0.130
+2.51%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
AVIR 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Atea Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
426.69M
股息TTM
0.00
市盈率 TTM
-2.52
每股收益TTM
-2.11
营业收入
--
净利润
-168.38M
净资产收益率
-52.58%
总资产收益率
-47.95%
Atea Pharmaceuticals Inc 财报日历
最新发布
8月 12, 2026
每股收益 / 预测值
-0.41
/-0.56
营业收入 / 预测值
--
/0.00
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
7.29%
-0.41
-42.56%
-0.57
-44.64%
-0.57
-44.15%
-0.53
7.74%
-0.44
46.54%
-0.40
15.39%
-0.40
7.15%
-0.37
-42.32%
-0.48
-76.87%
-0.75
-13.54%
-0.47
--
-0.40
--
-0.34
--
-0.43
--
-0.41
--
-0.98
--
--
--
--
--
--
--
--
营业收入
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
295.16%
192.18M
--
32.81M
净利润
11.38%
-32.93M
-32.59%
-45.44M
-33.76%
-44.87M
-34.98%
-42.05M
8.29%
-37.16M
45.75%
-34.27M
14.35%
-33.54M
6.01%
-31.15M
-43.78%
-40.52M
-78.11%
-63.17M
-13.75%
-39.16M
-310.89%
-33.14M
10.06%
-28.18M
15.71%
-35.47M
-129.40%
-34.43M
71.39%
-8.07M
-2136.06%
-31.34M
-237.00%
-42.08M
467.06%
117.13M
-59.99%
-28.19M
资产负债率
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00%
--
--
--
0.00%
--
0.00%
--
0.00%
--
0.00%
--
0.00%
--
0.00%
--
--
--
--
--
--
--
--
利润表
营业收入
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
295.16%
192.18M
--
32.81M
营业利润
15.27%
-35.10M
-26.98%
-48.01M
-55.14%
-54.71M
-46.79%
-45.45M
-16.92%
-41.42M
-23.74%
-37.81M
-24.40%
-35.27M
-0.99%
-30.97M
-20.89%
-35.43M
6.33%
-30.55M
-4.70%
-28.35M
-15.60%
-30.66M
-2.26%
-29.31M
-13.09%
-32.62M
-119.45%
-27.08M
-516.52%
-26.52M
-176.37%
-28.66M
-159.15%
-28.84M
363.90%
139.22M
167.48%
6.37M
净利润
11.38%
-32.93M
-32.59%
-45.44M
-33.76%
-44.87M
-34.98%
-42.05M
8.29%
-37.16M
45.75%
-34.27M
14.35%
-33.54M
6.01%
-31.15M
-43.78%
-40.52M
-78.11%
-63.17M
-13.75%
-39.16M
-310.89%
-33.14M
10.06%
-28.18M
15.71%
-35.47M
-129.40%
-34.43M
71.39%
-8.07M
-2136.06%
-31.34M
-237.00%
-42.08M
467.06%
117.13M
-59.99%
-28.19M
资产负债表
流动资产
-40.70%
228.66M
-39.31%
263.20M
-32.74%
310.99M
-30.96%
336.14M
-23.85%
385.60M
-20.97%
433.71M
-21.70%
462.36M
-19.30%
486.91M
-18.44%
506.37M
-13.22%
548.76M
-10.66%
590.46M
-11.53%
603.32M
-9.95%
620.83M
-11.33%
632.39M
-14.43%
660.92M
-19.10%
681.93M
-20.85%
689.45M
-15.11%
713.23M
-10.55%
772.40M
677.53%
842.95M
流动负债总额
39.79%
28.12M
53.43%
33.37M
113.86%
39.78M
-19.91%
20.18M
-24.42%
20.12M
-47.36%
21.75M
-42.54%
18.60M
33.33%
25.19M
64.73%
26.62M
234.20%
41.31M
75.21%
32.38M
20.85%
18.89M
-35.64%
16.16M
-56.79%
12.36M
-67.52%
18.48M
-94.03%
15.63M
-90.83%
25.11M
-88.75%
28.61M
-81.99%
56.88M
2322.82%
262.05M
总资产
-40.68%
232.28M
-39.30%
267.08M
-32.16%
315.22M
-30.14%
342.96M
-23.27%
391.61M
-20.44%
439.96M
-21.90%
464.67M
-19.26%
490.96M
-18.47%
510.38M
-13.34%
553.03M
-10.76%
594.97M
-11.43%
608.08M
-9.84%
626.03M
-11.02%
638.13M
-13.74%
666.71M
-18.60%
686.58M
-20.33%
694.34M
-14.69%
717.19M
-10.51%
772.89M
666.08%
843.50M
总负债
3.44%
28.12M
15.54%
33.37M
54.20%
39.78M
-16.19%
27.18M
-19.83%
27.19M
-40.65%
28.88M
-35.13%
25.80M
23.12%
32.44M
43.22%
33.91M
143.91%
48.66M
52.19%
39.78M
12.64%
26.34M
-30.11%
23.68M
-46.52%
19.95M
-58.39%
26.14M
-91.07%
23.39M
-87.62%
33.88M
-85.34%
37.30M
-80.11%
62.81M
2310.34%
262.05M
总权益
-43.98%
204.16M
-43.15%
233.71M
-37.24%
275.43M
-31.13%
315.78M
-23.52%
364.42M
-18.50%
411.08M
-20.95%
438.87M
-21.18%
458.52M
-20.90%
476.47M
-18.41%
504.37M
-13.33%
555.19M
-12.28%
581.73M
-8.80%
602.35M
-9.08%
618.18M
-9.79%
640.57M
14.06%
663.19M
10.47%
660.46M
15.97%
679.88M
29.62%
710.08M
485.94%
581.45M
现金流量表
经营净额
-12.82%
-37.08M
-51.79%
-46.39M
7.15%
-28.22M
-75.28%
-40.38M
22.11%
-32.87M
23.33%
-30.56M
-39.22%
-30.40M
-30.95%
-23.04M
-161.80%
-42.20M
-33.55%
-39.87M
-1.34%
-21.83M
17.19%
-17.59M
15.98%
-16.12M
49.41%
-29.85M
71.43%
-21.55M
-193.98%
-21.24M
-10.59%
-19.19M
-250.47%
-59.01M
-123.68%
-75.42M
338.40%
22.60M
投资净额
124.43%
34.31M
-65.26%
29.74M
1482.55%
46.59M
133.85%
41.30M
-87.74%
15.29M
50.71%
85.61M
-112.13%
-3.37M
-108.52%
-122.01M
167.77%
124.69M
132.03%
56.80M
-17.07%
27.77M
87.98%
-58.51M
2578.18%
46.56M
55736.36%
24.48M
837300.00%
33.49M
--
-486.98M
--
-1.88M
--
-44.00K
20.00%
-4.00K
100.00%
0.00
融资净额
100.00%
0.00
174.06%
257.00K
--
0.00
-9762.39%
-11.30M
--
-14.09M
-331.33%
-347.00K
--
0.00
27.17%
117.00K
--
0.00
-9.09%
150.00K
--
0.00
-37.41%
92.00K
--
0.00
-26.01%
165.00K
-100.00%
0.00
-81.51%
147.00K
-100.00%
0.00
-52.65%
223.00K
-99.97%
142.00K
187.08%
795.00K
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
Atea Pharmaceuticals Inc的流动资产是多少?
根据Atea Pharmaceuticals Inc的FY2025财报,流动资产为310.99M(同比变化-32.74)。
Atea Pharmaceuticals Inc的总资产是多少?
根据Atea Pharmaceuticals Inc的FY2025财报,Atea Pharmaceuticals Inc的总资产为315.22M(同比变化-32.16)。
Atea Pharmaceuticals Inc的总负债是多少?
根据Atea Pharmaceuticals Inc的FY2025财报,Atea Pharmaceuticals Inc的总负债为39.78M(同比变化54.20)。
Atea Pharmaceuticals Inc的总权益是多少?
根据Atea Pharmaceuticals Inc的FY2025财报,Atea Pharmaceuticals Inc的总权益为275.43M(同比变化-37.24)。
Atea Pharmaceuticals Inc的净营业收入是多少?
根据Atea Pharmaceuticals Inc的FY2025财报,Atea Pharmaceuticals Inc的净营业收入为-179.40M(同比变化-35.68)。
Atea Pharmaceuticals Inc的净投资是多少?
根据Atea Pharmaceuticals Inc的FY2025财报,Atea Pharmaceuticals Inc的净投资为188.79M(同比变化236.50)。
Atea Pharmaceuticals Inc的净融资是多少?
根据Atea Pharmaceuticals Inc的FY2025财报,Atea Pharmaceuticals Inc的净融资为-25.75M(同比变化-9742.32)。
Atea Pharmaceuticals Inc的每股收益(EPS)是多少?
根据Atea Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-1.94(同比变化2.76)。
Atea Pharmaceuticals Inc的净利润是多少?
根据Atea Pharmaceuticals Inc的FY2025财报,净利润为-158.35M(同比变化5.96)。
Atea Pharmaceuticals Inc的股东权益回报率(ROE)是多少?
根据Atea Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-44.34(同比变化-30.87)。
Atea Pharmaceuticals Inc的资产回报率(ROA)是多少?
根据Atea Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-40.61(同比变化-27.77)。
Atea Pharmaceuticals Inc的营业利润是多少?
根据Atea Pharmaceuticals Inc的FY2025财报,营业利润为-179.40M(同比变化-35.68)。